Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
Dia-Präsentation von Merck Gesellschaft mbH. Micardis(R) - Micardis Plus(R) - Pharmakologie (14 Abbildungen) Übersicht
| ||||||||||||||||||
Abbildung 5: Plasma-Halbwertzeit Telmisartan has a 24-h plasma half-life, which is the longest any ARB.1,2 The long plasma half-life ensures that the antihypertensive efficacy is maintained for the full 24-h dosing interval, including into the early morning hours. 1. Burnier M, Brunner HR. Angiotensin II receptor antagonists. Lancet 2000; 355: 637–645. 2. Brunner HR. The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview. J Hum Hypertens 2002;16 (Suppl 2): S13–S16. |
Abbildung 5: Plasma-Halbwertzeit
Telmisartan has a 24-h plasma half-life, which is the longest any ARB.1,2 The long plasma half-life ensures that the antihypertensive efficacy is maintained for the full 24-h dosing interval, including into the early morning hours. 1. Burnier M, Brunner HR. Angiotensin II receptor antagonists. Lancet 2000; 355: 637–645. 2. Brunner HR. The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview. J Hum Hypertens 2002;16 (Suppl 2): S13–S16. |